Results 121 to 130 of about 75,381 (216)

[Comunicaciones XLVIII Reunión de la Sociedad de la Sociedad de Neurofisiología Clínica de las Comunidades de Valencia y Murcia]. [PDF]

Rev Neurol
europepmc   +1 more source

[An overview of home care for patients with chronic diseases in Latin America: A scoping reviewPanorama da atenção domiciliar para pacientes com doenças crônicas na América Latina: revisão de escopo]. [PDF]

Rev Panam Salud Publica
Fonseca Valencia C, Botero Toro A, Forero AP, González-Rodríguez J, Pinzón Espitia OL, Murcia-Soriano LF.   +5 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

[XLVI REUNIÓN ANUAL DE LA SOCIEDAD ANDALUZA DE NEUROLOGÍA]. [PDF]

Rev Neurol
europepmc   +1 more source

Limitaciones metodológicas del artículo “Factores de riesgo para colecistitis aguda gangrenosa”. [PDF]

Acta Gastroenterol Latinoam
Palomares Rutte JF, Chambi Mejía YC.
europepmc   +1 more source

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

Molecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain, Yann Le Page, Frédéric Percevault, Emmanuelle Becker, Luc Negroni, Almudena Fernandez, Marta Cantero, Diego Muñoz‐Santos, Lluís Montoliu, Cyrille Garnier, Michael Primig   +10 more
wiley   +1 more source

CONCLUSIONES

Revista Española de Salud Pública, 2009
Neus Cardeñosa Marín
doaj  

Conclusiones. Esto recién empieza...

Telondefondo : Revista de Teoría y Crítica Teatral, 2018
UBACyT Los trabajadores del espectáculo en Buenos Aires: la especificidad laboral...
doaj   +1 more source

[Efficiency after integrating a hospital with a 'new management model']. [PDF]

An Sist Sanit Navar
Cacho Uzal M, Cueva Ares J, Lopez-Juiz F, Reyes Santías F.   +3 more
europepmc   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

Molecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu, Xixi Lin, Emil Mladenov, Veronika Mladenova, Jürgen Thomale, Ali Sak, Yao Wang, Yunxuan Deng, Eleni Gkika, Martin Stuschke, George Iliakis   +10 more
wiley   +1 more source